OBJECTIVE: To study plasma and dietary linoleic acid (LA) in relation to type 2 diabetes risk in post-myocardial infarction (MI) patients. RESEARCH DESIGN AND METHODS: We included 3,257 patients aged 60-80 years (80% male) with a median time since MI of 3.5 years from the Alpha Omega Cohort and who were initially free of type 2 diabetes. At baseline (2002-2006), plasma LA was measured in cholesteryl esters, and dietary LA was estimated with a 203-item food-frequency questionnaire. Incident type 2 diabetes was ascertained through self-reported physician diagnosis and medication use. Hazard ratios (with 95% CIs) were calculated by Cox regressions, in which dietary LA isocalorically replaced the sum of saturated (SFA) and trans fatty acids (TFA). RESULTS: Mean ± SD circulating and dietary LA was 50.1 ± 4.9% and 5.9 ± 2.1% energy, respectively. Plasma and dietary LA were weakly correlated (Spearman r = 0.13, P < 0.001). During a median follow-up of 41 months, 171 patients developed type 2 diabetes. Plasma LA was inversely associated with type 2 diabetes risk (quintile [Q]5 vs. Q1: 0.44 [0.26, 0.75]; per 5%: 0.73 [0.62, 0.86]). Substitution of dietary LA for SFA+TFA showed no association with type 2 diabetes risk (Q5 vs. Q1: 0.78 [0.36, 1.72]; per 5% energy: 1.18 [0.59, 2.35]). Adjustment for markers of de novo lipogenesis attenuated plasma LA associations. CONCLUSIONS: In our cohort of post-MI patients, plasma LA was inversely related to type 2 diabetes risk, whereas dietary LA was not related. Further research is needed to assess whether plasma LA indicates metabolic state rather than dietary LA in these patients.
OBJECTIVE: To study plasma and dietary linoleic acid (LA) in relation to type 2 diabetes risk in post-myocardial infarction (MI) patients. RESEARCH DESIGN AND METHODS: We included 3,257 patients aged 60-80 years (80% male) with a median time since MI of 3.5 years from the Alpha Omega Cohort and who were initially free of type 2 diabetes. At baseline (2002-2006), plasma LA was measured in cholesteryl esters, and dietary LA was estimated with a 203-item food-frequency questionnaire. Incident type 2 diabetes was ascertained through self-reported physician diagnosis and medication use. Hazard ratios (with 95% CIs) were calculated by Cox regressions, in which dietary LA isocalorically replaced the sum of saturated (SFA) and trans fatty acids (TFA). RESULTS: Mean ± SD circulating and dietary LA was 50.1 ± 4.9% and 5.9 ± 2.1% energy, respectively. Plasma and dietary LA were weakly correlated (Spearman r = 0.13, P < 0.001). During a median follow-up of 41 months, 171 patients developed type 2 diabetes. Plasma LA was inversely associated with type 2 diabetes risk (quintile [Q]5 vs. Q1: 0.44 [0.26, 0.75]; per 5%: 0.73 [0.62, 0.86]). Substitution of dietary LA for SFA+TFA showed no association with type 2 diabetes risk (Q5 vs. Q1: 0.78 [0.36, 1.72]; per 5% energy: 1.18 [0.59, 2.35]). Adjustment for markers of de novo lipogenesis attenuated plasma LA associations. CONCLUSIONS: In our cohort of post-MI patients, plasma LA was inversely related to type 2 diabetes risk, whereas dietary LA was not related. Further research is needed to assess whether plasma LA indicates metabolic state rather than dietary LA in these patients.
Authors: Tomas Jernberg; Pål Hasvold; Martin Henriksson; Hans Hjelm; Marcus Thuresson; Magnus Janzon Journal: Eur Heart J Date: 2015-01-13 Impact factor: 29.983
Authors: Johanna M Geleijnse; Erik J Giltay; Evert G Schouten; Janette de Goede; Linda M Oude Griep; Anna M Teitsma-Jansen; Martijn B Katan; Daan Kromhout Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: Geng Zong; Gang Liu; Walter C Willett; Anne J Wanders; Marjan Alssema; Peter L Zock; Frank B Hu; Qi Sun Journal: Diabetes Care Date: 2019-06-10 Impact factor: 19.112
Authors: Diana P Brostow; Andrew O Odegaard; Woon-Puay Koh; Sue Duval; Myron D Gross; Jian-Min Yuan; Mark A Pereira Journal: Am J Clin Nutr Date: 2011-05-18 Impact factor: 7.045
Authors: Jason H Y Wu; Matti Marklund; Fumiaki Imamura; Nathan Tintle; Andres V Ardisson Korat; Janette de Goede; Xia Zhou; Wei-Sin Yang; Marcia C de Oliveira Otto; Janine Kröger; Waqas Qureshi; Jyrki K Virtanen; Julie K Bassett; Alexis C Frazier-Wood; Maria Lankinen; Rachel A Murphy; Kalina Rajaobelina; Liana C Del Gobbo; Nita G Forouhi; Robert Luben; Kay-Tee Khaw; Nick Wareham; Anya Kalsbeek; Jenna Veenstra; Juhua Luo; Frank B Hu; Hung-Ju Lin; David S Siscovick; Heiner Boeing; Tzu-An Chen; Brian Steffen; Lyn M Steffen; Allison Hodge; Gudny Eriksdottir; Albert V Smith; Vilmunder Gudnason; Tamara B Harris; Ingeborg A Brouwer; Claudine Berr; Catherine Helmer; Cecilia Samieri; Markku Laakso; Michael Y Tsai; Graham G Giles; Tarja Nurmi; Lynne Wagenknecht; Matthias B Schulze; Rozenn N Lemaitre; Kuo-Liong Chien; Sabita S Soedamah-Muthu; Johanna M Geleijnse; Qi Sun; William S Harris; Lars Lind; Johan Ärnlöv; Ulf Riserus; Renata Micha; Dariush Mozaffarian Journal: Lancet Diabetes Endocrinol Date: 2017-10-12 Impact factor: 32.069
Authors: Kristin Torgersen; Zillur Rahman; Shahram Bahrami; Guy Frederick Lanyon Hindley; Nadine Parker; Oleksandr Frei; Alexey Shadrin; Kevin S O'Connell; Martin Tesli; Olav B Smeland; John Munkhaugen; Srdjan Djurovic; Toril Dammen; Ole A Andreassen Journal: PLoS Genet Date: 2022-05-13 Impact factor: 6.020